Management of amiodarone-induced thyrotoxicosis in Latin America: An electronic survey

Clinical Endocrinology

Volumn 65, Issue 4, 2006, Pages 433-438

  Diehl, Leandro Arthur ^a   Romaldini, João Hamilton ^b   Graf, Hans ^c   Bartalena, Luigi ^d   Martino, Enio ^e   Albino, Claudio Cordeiro ^f   Wiersinga, Wilmar M ^g  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b PONTIFÍCIA UNIVERSIDADE CATÓLICA DE CAMPINAS   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^d UNIVERSITY OF INSUBRIA   (Italy)

^e UNIVERSITY OF PISA   (Italy)

^f Diabetes and Endocrinology Institute of Maringá   (Brazil)

^g Academic Clinical Centre of Amsterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; GLUCOCORTICOID; POTASSIUM PERCHLORATE; THIONAMIDE;

ADULT; ASPIRATION BIOPSY; AUTOIMMUNITY; CASE REPORT; CLINICAL ASSESSMENT; DIAGNOSTIC TEST; DOPPLER ECHOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SOUTH AND CENTRAL AMERICA; THYROTOXICOSIS;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ANTITHYROID AGENTS; ARRHYTHMIA; ARRHYTHMIAS, CARDIAC; DRUG ADMINISTRATION SCHEDULE; GLUCOCORTICOIDS; HUMANS; HYPOTHYROIDISM; INCIDENCE; IODINE; LATIN AMERICA; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; SOCIETIES, MEDICAL; THYROID FUNCTION TESTS; THYROID HORMONES; THYROIDECTOMY; THYROTOXICOSIS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 33748807457     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02590.x     Document Type: Review

References (30)

1. Goldschlager, N., Epstein, A.E., Naccarelli, G., Olshansky, B. & Singh, B. (2000) Practical guidelines for clinicians who treat patients with amiodarone. Archives of Internal Medicine, 160, 1741-1748.
2. Kennedy, R.L., Griffiths, H. & Gray, T.A. (1989) Amiodarone and the thyroid. Clinical Chemistry, 35, 1882-1887.
3. Martino, E., Safran, M., Aghini-Lombardi, F., Rajatanavin, R., Lenziardi, M., Fay, M., Pacchiarotti, A., Aronin, N., Macchia, E. & Haffajee, C. (1984) Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Annals of Internal Medicine, 101, 28-34.
4. Trip, M.D., Wiersinga, W. & Plomp, T.A. (1991) Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. American Journal of Medicine, 91, 507-511.
5. Bartalena, L., Brogioni, S., Grasso, L., Bogazzi, F., Burelli, A. & Martino, E. (1996) Treatment of amiodarone-induced thyrotoxicosis. A difficult challenge: results of a prospective study. Journal of Clinical Endocrinology and Metabolism, 81, 2930-2933.
6. Bartalena, L., Bogazzi, F. & Martino, E. (2002) Amiodarone-induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge. Clinical Endocrinology, 56, 23-24.
7. Bartalena, L., Wiersinga, W.M., Tanda, M.L., Bogazzi, F., Piantanida, E., Lai, A. & Martino, E. (2004) Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clinical Endocrinology, 61, 494-502.
8. Diehl, L.A., Garcia, V., Bonnema, S.J., Hegedüs, L., Albino, C.C. & Graf, H. (2005) Management of the nontoxic multinodular goiter in Latin America: comparison with North America and Europe, an electronic survey. Journal of Clinical Endocrinology and Metabolism, 90, 117-123.
9. International Council for the Control of Iodine Deficiency Disorders (2005) Current iodine deficiency disorders status database. ICCIDD, Ottawa. Available online at: http://indorgs.virginia.edu/iccidd/mi/cidds.html (last accessed 15 November 2005; last updated 14 August 2004).
10. Martino, E., Bartalena, L., Bogazzi, F. & Braverman, L.E. (2001) The effects of amiodarone on the thyroid. Endocrine Reviews, 22, 240-254.
11. Bartalena, L., Grasso, L., Brogioni, S., Aghini-Lombardi, F., Braverman, L.E. & Martino, E. (1994) Serum interleukin-6 in amiodarone-induced thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism, 78, 423-427.
12. Eaton, S.E.M., Euinton, H.A., Newman, C.M., Weetman, A.P. & Bennet, W.M. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of color-flow Doppler sonography. Clinical Endocrinology, 56, 33-38.
13. Daniels, G.H. (2001) Amiodarone-induced thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism, 86, 3-8.
14. Newman, C.M., Price, A., Davies, D.W., Gray, T.A. & Weetman, A.P. (1998) Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart, 79, 121-127.
15. Bogazzi, F., Bartalena, L., Brogioni, S., Mazzeo, S., Vitti, P., Burelli, A., Bartolozzi, C. & Martino, E. (1997) Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid, 7, 541-545.
16. Martino, E., Aghini-Lombardi, F., Mariotti, S., Lenziardi, M., Baschieri, L., Braverman, L.E. & Pinchera, A. (1986) Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. Journal of Endocrinological Investigation, 9, 201-207.
17. Wolff, J. (1998) Perchlorate and the thyroid gland. Pharmacological Reviews, 50, 89-105.
18. Chopra, I.J. & Baber, K. (2001) Use of oral cholecystographic agents in the treatment of amiodarone-induced hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 86, 4707-4710.
19. Bogazzi, F., Aghini-Lombardi, F., Cosci, C., Lupi, I., Santini, F., Tanda, M.L., Miccoli, P., Basolo, F., Pinchera, A., Bartalena, L., Braverman, L.E. & Martino, E. (2002) Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy. Journal of Endocrinological Investigation, 25, 176-180.
20. Diamond, T.H., Rajagopal, R., Ganda, K., Manoharan, A. & Luk, A. (2004) Plasmapheresis as a potential treatment option for amiodarone-induced thyrotoxicosis. Internal Medicine Journal, 34, 369-370.
21. Aghini-Lombardi, F., Mariotti, S., Fosella, P.V., Grasso, L., Pinchera, A., Braverman, L.E. & Martino, E. (1993) Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole. Journal of Endocrinological Investigation, 16, 823-826.
22. Spanknebel, K., Chabot, J.A., Digiorgi, M., Cheung, K., Lee, S., Allendorf, J. & LoGerfo, P. (2005) Thyroidectomy using local anesthesia: a report of 1025 cases over 16 years. Journal of the American College of Surgeons, 201, 375-385.
23. Lombardi, C.P., Rafaelli, M., Modesti, C., Boscherini, M. & Bellantone, R. (2004) Video-assisted thyroidectomy under local anesthesia. American Journal of Surgery, 187, 515-518.
24. Tedelind, S., Larsson, F., Johanson, C., van Beeren, H.C., Wiersinga, W.M., Nyström, E. & Nilsson, M. (2006) Amiodarone inhibits thyroidal iodide transport in vitro by a cyclic adenosine 5′-monophosphate- and iodine-independent mechanism. Endocrinology, 147, 2936-2943.
25. Iskandar, S.B., Jordan, R.M. & Peiris, A.N. (2004) Treating amiodarone-induced thyrotoxicosis with radioactive iodine. Tennessee Medicine, 97, 408-410.
26. Dietlein, M. & Schicha, H. (2005) Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations. Experimental and Clinical Endocrinology and Diabetes, 113, 145-151.
27. Basaria, S. & Cooper, D.S. (2005) Amiodarone and the thyroid. American Journal of Medicine, 118, 706-714.
28. Loh, K.C. (2000) Amiodarone-induced thyroid disorders: a clinical review. Postgraduate Medical Journal, 76, 133-140.
29. Osman, F., Franklyn, J.A., Sheppard, M.C. & Gammage, M.D. (2002) Successful treatment of amiodarone-induced thyrotoxicosis. Circulation, 105, 1275-1277.
30. Uzan, L., Guignat, L., Meune, C., Mouly, S., Weber, S., Bertagna, X., Bertherat, J., Thomopoulos, P. & Duboc, D. (2006) Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosis. Drug Safety, 29, 231-236.